Condition

Exfoliation Syndrome

ClinicalTrials.gov condition label

Clinical trials8

Recruiting1

Common interventions10

Lead sponsors shown7

Clinical trials

8 shown

Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) ShuntNCT06691555 · 2024-11-08

Imaging Lens Deposits in Exfoliation SyndromeNCT02042703 · 2014-02-01

A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or GlaucomaNCT01936389 · 2013-09-01

Central Corneal Thickness in GlaucomaNCT01023997 · 2008-01-01

Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular HypertensionNCT01126203 · 2006-09-01

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed CombinationNCT00331240 · 2006-03-01

Assessing Cosopt Switch PatientsNCT00273442 · 2005-11-01

The International Collaborative Exfoliation Syndrome Treatment StudyNCT00804115 · 2000-08-01

Common interventions

ALTPROCEDURE1 anterior segment OCTDEVICE1 AR-12286DRUG1 dorzolamide/timolol maleate fixed combinationDRUG1 Latanoprost with Pilocarpine vs Timolol or CosoptDRUG1 placebo (artificial tears)DRUG1 SLTPROCEDURE1 Suprachoroidal silicone tube (SST) shuntDEVICE1 timolol maleateDRUG1 travoprost/timolol fixed combinationDRUG1

Leading sponsors

Aristotle University Of Thessaloniki2 Davinci LTD1 Duke University1 Pharmaceutical Research Network1 Robert Ritch, MD, LLC.1 The New York Eye & Ear Infirmary1 University of Calgary1

Trial status mix

COMPLETED5

RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

PHASE32

NA1

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.